HDM1005
Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes
Huadong Medicine · Phase 3 · Recruiting · Enrollment 825
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HDM1005 Cohort 1 | Obesity or overweight | n/r | 52 | n/r | n/r |
| HDM1005 Cohort 2 | Obesity or overweight | n/r | 52 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 52 | n/r | n/r |